Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: Eritoran vs placebo in patients with severe sepsis
2005-005537-35Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis comparing Eritoran tetrasodium with Placebo (2 arms). Primary endpoint: All-cause mortality at Day 28. Started Jun 2006; status: completed.
02
Drugs
eritoran
03
Conditions
sepsis
Beyond the preview
Go deeper on 2005-005537-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005537-35.